Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Hypopharyngeal Neoplasms × sacituzumab govitecan × Clear all

Sponsor

Conditions

Breast Neoplasms 4 Triple Negative Breast Neoplasms 3 Carcinoma, Non-Small-Cell Lung 2 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Small Cell Lung Carcinoma 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasm Metastasis 1 Metastatic Solid Tumors 1 Glioblastoma 1 Esophageal Neoplasms 1 Endometrial Neoplasms 1 Carcinoma, Renal Cell 1 Carcinoma, Ovarian Epithelial 1 Carcinoma, Hepatocellular 1

Interventions

Cetuximab 3 Radiotherapy, Intensity-Modulated 2 Cisplatin 2 Bupropion 2 pembrolizumab 1 durvalumab 1 Tobacco Use Cessation Devices 1 Radiation 1 Psychiatric Rehabilitation 1 Polymerase Chain Reaction 1 Pilocarpine 1 Oral Hygiene 1 Immunoglobulin G 1 Gene Expression Profiling 1 Fluorodeoxyglucose F18 1 FPP(RGD)2 1 Early Intervention, Educational 1 Drug Therapy 1 Disulfides 1 Counseling 1 Celecoxib 1 Acupuncture Therapy 1 130-nm albumin-bound paclitaxel 1 (225)Ac-DOTA-c(RGDyK) 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡